Chester County News and Community Website
MALVERN, PA — Vishay Intertechnology, Inc. (NYSE: VSH) will release its financial results for the first quarter ended April 4, 2026, before the New York Stock Exchange opens on Wednesday, …
Vishay to Report First-Quarter 2026 Results May 13 Read More
VALLEY FORGE, PA — UGI Corporation (NYSE: UGI) will report its fiscal 2026 second-quarter results after the market closes on May 6 and host a conference call the following morning, …
UGI Corporation to Report Q2 Results on May 6 Read More
EXTON, PA — West Pharmaceutical Services, Inc. (NYSE: WST) said it will release first-quarter 2026 financial results before markets open Thursday, April 23, and will host a conference call at …
West Pharmaceutical Services to Report Q1 Results April 23 Read More
CHESTERBROOK, PA — Vishay Precision Group Inc. (NYSE: VPG) will release its first-quarter fiscal 2026 financial results before the market opens on Tuesday, May 12.
Vishay Precision Group Sets Date for First-Quarter 2026 Results Read More
EXTON, PA — Bentley Systems, Incorporated (Nasdaq: BSY) will release its first-quarter 2026 financial results before markets open on Thursday, May 7, followed by a webcast hosted by senior management …
Bentley Systems Sets May 7 Date for First-Quarter Results Read More
MALVERN, PA — CubeSmart (NYSE: CUBE) will release its financial results for the first quarter ended March 31, 2026, after market close on Thursday, April 30, followed by a conference …
CubeSmart to Report First-Quarter 2026 Results April 30 Read More
WAYNE, PA — Palvella Therapeutics, Inc. (Nasdaq: PVLA) recently reported its full-year 2025 financial results and outlined progress across its QTORIN drug development pipeline, including plans to submit a new …
Palvella Reports 2025 Results, Advances QTORIN Drug Pipeline Read More
MALVERN, PA — Neuronetics, Inc. (Nasdaq: STIM) reported higher fourth-quarter and full-year 2025 revenue, narrowed its losses, posted positive operating cash flow in the fourth quarter, and said Dan Reuvers …
Neuronetics Reports Higher Revenue, Narrows Loss, Sets 2026 Outlook Read More
MALVERN, PA — Annovis Bio Inc. (NYSE: ANVS) reported its 2025 financial results and said it advanced late-stage clinical development of its investigational drug buntanetap, including launching a Phase 3 …
Annovis Reports 2025 Results, Advances Buntanetap Trials Read More
WAYNE, PA — Trinseo (NYSE: TSE) reported a fourth-quarter 2025 net loss of $251 million and a full-year net loss of $546 million, driven by lower sales volumes, pricing pressure, …
Trinseo Reports 2025 Loss as Sales Decline and Restructuring Costs Rise Read More